Compare
Compare peptides
Pick any two or three profiled peptides to see evidence level, regulatory status, proposed mechanism and research focus side by side. Editorial comparisons below go deeper on the pairs readers ask about most.
Editorial comparisons
Comparison
BPC-157 vs TB-500
The two most popular "healing peptides" compared on what has actually been studied, in whom, and what the FDA has said about each.
Comparison
CJC-1295 vs ipamorelin vs tesamorelin
Three growth-hormone-axis peptides compared: one FDA-approved with phase 3 trials, two with only early human pharmacology and discontinued development programmes.
Comparison
Semaglutide vs tirzepatide
The two approved incretin peptides for weight and glucose compared on trial results, mechanism, approvals, cardiovascular evidence, and what remains uncertain.